A fingerprick blood test can track muscle damage and recovery, helping athletes manage performance and reduce injury risk after intense exercise like marathons
Alzheimer’s currently affects over 55 million people worldwide, with cases expected to triple by 2050. Advances in diagnostic methods that are faster, less invasive, and more affordable could enable timely intervention for the neurodegenerative disease. However, the report notes that questions remain about their real-world impact on patient outcomes.
